Date: 2011-09-25
Type of information: Services contract
Compound: shrimp alkaline phosphatase
Company: Biotec Pharmacon (Norway) Affymetrix (USA)
Therapeutic area:
Type agreement: Supply
Action mechanism:
Disease:
Details: Biotec Pharmacon ASA, via its subsidiary ArcticZymes AS, and Affymetrix Inc. have signed a new non-exclusive supply agreement for deliveries of ArcticZymes\' top-selling enzyme shrimp alkaline phosphatase (SAP). Affymetrix has previously held an exclusive right to distribute SAP, whereas the new agreement enables ArcticZymes to offer SAP for sale also to other customers. At the same time the new agreement provides Affymetrix with a secure long term supply of SAP at competitive prices and non-exclusive rights to market, distribute and sell the product or combinations with other products for life science and diagnostic applications. The new agreement is effective from 23rd September, 2011 and initially runs through December 2017.
Financial terms:
Latest news:
